Sandra Nagale, PhD

AI's potential for disrupting the medical device industry is undeniable. Major players are making strategic moves to solidify their position in the future of medtech: acquisitions, newly established executive roles devoted to AI, and partnerships with tech leaders like NVIDIA all signal a commitment to integration. This session will feature AI leaders from Medtronic, Boston Scientific, and Sanofi sharing insights into their AI strategies, specific use cases showcasing current successes, and their vision for how AI will reshape the industry in years to come.